Sign in to view content

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

Michael S. Ip, MD

Video
Published 2018

Related

Combination Therapy With Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial
Jeffrey S. Heier, MD
Annual Meeting Talks
2018
Evaluation of an Automated Severity Score in Retinopathy of Prematurity
J. Peter Campbell, MD, MPH
Annual Meeting Talks
2018
A Real-World Analysis in 49,485 Eyes of Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Neovascular AMD Patients
David F. Williams, MD, MBA
Annual Meeting Talks
2018

Category: Retinal Vascular Disease

See more